• Heron Therapeutics updates investors on business progress as development pipeline remains the key va ad-hoc-news.de Tue, 07 Jul 2026 17:24:47 GMT
• H.C. Wainwright Maintains Heron Therapeutics(HRTX.US) With Buy Rating, Maintains Target Price $4 富途牛牛 Sun, 05 Jul 2026 01:46:06 GMT
• Is Heron Therapeutics, Inc. (HRTX) Stock a Recovery Opportunity After Cinvanti Patent Court Ruling? Yahoo Finance Tue, 30 Jun 2026 07:00:00 GMT
• Heron Therapeutics (HRTX) Stock Sees Fair Value Cut After Cinvanti Patent Decision Yahoo Finance Sat, 27 Jun 2026 07:00:00 GMT
• heron therapeutics inc (hrtx) technical analysis: support, resistance, indicators & moving averages TradingKey Sat, 27 Jun 2026 02:16:50 GMT
• Heron Therapeutics Receives Nasdaq Minimum Bid Price Notification Moomoo Fri, 26 Jun 2026 10:16:12 GMT
• heron therapeutics | 4: statement of changes in beneficial ownership of securities-officer forbes william p Moomoo Fri, 26 Jun 2026 09:13:10 GMT
• Heron Therapeutics Inc Actuals & Estimates (NASDAQ:HRTX) TradingView Fri, 26 Jun 2026 07:11:46 GMT
• heron therapeutics, inc. 8-k filing: nasdaq listing status, company details & key sec disclosures (june 25, 2026) Minichart Fri, 26 Jun 2026 02:19:00 GMT
• enterprise value to ebitda forward of heron therapeutics, inc. – nasdaq:hrtx TradingView Thu, 25 Jun 2026 20:24:37 GMT
• enterprise value to ebit forward of heron therapeutics, inc. – nasdaq:hrtx TradingView Thu, 25 Jun 2026 20:12:29 GMT
• price to sales forward of heron therapeutics, inc. – nasdaq:hrtx TradingView Thu, 25 Jun 2026 19:41:34 GMT
• Enterprise value to revenue forward of Heron Therapeutics, Inc. – NASDAQ:HRTX TradingView Thu, 25 Jun 2026 19:24:14 GMT
• Nasdaq warns Heron Therapeutics (NASDAQ: HRTX) on sub-$1.00 bid price Stock Titan Thu, 25 Jun 2026 07:00:00 GMT
• Heron Therapeutics Disclosed Failure to Satisfy a Continued Listing Rule or Standard TradingView Thu, 25 Jun 2026 07:00:00 GMT
• HRTX Q1 2026 Earnings: EPS Misses Estimates Sharply as Losses Widen, Shares Decline 2.33% - Pre-Announcement Alert dars.gov.et Wed, 24 Jun 2026 07:00:00 GMT
• heron therapeutics stock - long-term strategy under pressure after reverse split and nasdaq warning AD HOC NEWS Sat, 20 Jun 2026 19:37:34 GMT
• Heron Therapeutics (HRTX) Surges 7.8%: Testing Key Resistance at $0.44 - Advance Decline Volume dars.gov.et Sat, 20 Jun 2026 07:00:00 GMT
• heron therapeutics inc (hrtx) valuation: pe, pb & fair value analysis TradingKey Fri, 19 Jun 2026 06:04:23 GMT
• heron therapeutics inc (hrtx) valuation: pe, pb & fair value analysis TradingKey Thu, 18 Jun 2026 07:00:00 GMT
• heron therapeutics inc (hrtx) financial health: profitability & balance sheet analysis TradingKey Thu, 18 Jun 2026 07:00:00 GMT
• heron therapeutics inc (hrtx) technical analysis: support, resistance, indicators & moving averages TradingKey Thu, 18 Jun 2026 07:00:00 GMT
• heron therapeutics inc (hrtx) risk assessment: volatility, financial risk & investment risk TradingKey Thu, 18 Jun 2026 07:00:00 GMT
• heron therapeutics inc (hrtx) shareholder structure: major shareholders & institutional holdings TradingKey Wed, 17 Jun 2026 21:52:49 GMT
• Heron Therapeutics Inc (HRTX) Dividends & Stock Splits: Historical Payouts and Event Timeline TradingKey Wed, 17 Jun 2026 21:52:48 GMT
• Heron Therapeutics Inc (HRTX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution TradingKey Wed, 17 Jun 2026 21:33:41 GMT
• Heron Therapeutics Stock - Shareholders back equity plans and tax measure at 2026 meeting ad-hoc-news.de Wed, 17 Jun 2026 16:15:54 GMT
• Heron Therapeutics (NASDAQ: HRTX) CFO exercises RSUs and withholds shares for taxes Stock Titan Wed, 17 Jun 2026 07:00:00 GMT
• heron therapeutics inc (hrtx) financial health: profitability & balance sheet analysis TradingKey Tue, 16 Jun 2026 21:02:37 GMT
• heron therapeutics inc (hrtx) valuation: pe, pb & fair value analysis TradingKey Tue, 16 Jun 2026 20:59:55 GMT
• heron therapeutics inc (hrtx) earnings forecast: future eps & revenue growth estimates TradingKey Tue, 16 Jun 2026 20:52:50 GMT
• heron therapeutics inc (hrtx) risk assessment: volatility, financial risk & investment risk TradingKey Tue, 16 Jun 2026 20:51:52 GMT
• Heron Therapeutics (HRTX) holders approve board, equity share increases and tax plan Stock Titan Tue, 16 Jun 2026 07:00:00 GMT
• heron therapeutics stockholders approve director slate and plan amendments at annual meeting Investing.com UK Tue, 16 Jun 2026 07:00:00 GMT
• Heron Therapeutics In A Tough Spot After Cinvanti Court Loss (Rating Downgrade) Seeking Alpha Wed, 10 Jun 2026 07:00:00 GMT
• H.C. Wainwright Maintains Heron Therapeutics(HRTX.US) With Buy Rating, Maintains Target Price $2 Moomoo Mon, 08 Jun 2026 07:00:00 GMT
• heron therapeutics (hrtx) evp converts 12,500 rsus into common shares Stock Titan Mon, 08 Jun 2026 07:00:00 GMT
• tang kevin c's strategic acquisition in aurinia pharmaceuticals inc GuruFocus Sat, 06 Jun 2026 01:39:05 GMT
• hrtx maintains buy rating -- price target lowered to $2.00 by hc wainwright GuruFocus Thu, 04 Jun 2026 01:52:30 GMT
• heron therapeutics appeals ruling invalidating cinvanti patents The Globe and Mail Wed, 03 Jun 2026 23:20:00 GMT
• h.c. wainwright maintains heron therapeutics(hrtx.us) with buy rating, cuts target price to $2 Moomoo Wed, 03 Jun 2026 11:33:00 GMT
• heron therapeutics to appeal delaware court ruling invalidating cinvanti® patents Minichart Wed, 03 Jun 2026 07:00:00 GMT
• U.S. District Court Issues Decision Regarding CINVANTI® Patents GlobeNewswire Tue, 02 Jun 2026 07:00:00 GMT
• Heron Therapeutics loses patent case over Cinvanti drug Investing.com Tue, 02 Jun 2026 07:00:00 GMT
• Heron Therapeutics (HRTX) Faces Patent Setback in Cinvanti Litigation GuruFocus Tue, 02 Jun 2026 07:00:00 GMT
• Court rules CINVANTI patents invalid; Heron readies appeal Stock Titan Tue, 02 Jun 2026 07:00:00 GMT
• CINVANTI patent claims invalidated as Heron Therapeutics (NASDAQ: HRTX) plans appeal Stock Titan Tue, 02 Jun 2026 07:00:00 GMT
• Why Did FULC, MVIS, HRTX Stocks Plunge To 52-Week Lows Today? Yahoo Finance Tue, 02 Jun 2026 07:00:00 GMT
• Acute Pain Market Set for Strong Expansion Through 2036 Amid Rising Investment Interest – DelveInsight | Vertex Pharma, Heron Ther... Barchart.com Tue, 02 Jun 2026 07:00:00 GMT
• us court invalidates key heron therapeutics patents on cinvanti; company plans to appeal. Pluang Tue, 02 Jun 2026 07:00:00 GMT
• hrtx stock price, quote & chart | heron therapeutics inc (nasdaq:hrtx) ChartMill Tue, 02 Jun 2026 07:00:00 GMT
• 12 health care stocks moving in monday's after-market session - abivax (nasdaq:abvx), aditxt inc ordinary Benzinga Mon, 01 Jun 2026 07:00:00 GMT
• heron therapeutics stock (us4277461020): q1 2026 loss narrows as nasdaq-listed biotech trades under AD HOC NEWS Mon, 01 Jun 2026 07:00:00 GMT
• heron outlines $173m-$183m 2026 net product sales outlook as it targets return to positive adjusted ebitda MSN Wed, 27 May 2026 08:31:38 GMT
• number of shareholders of heron therapeutics, inc. – nasdaq:hrtx TradingView Wed, 27 May 2026 02:18:41 GMT
• heron therapeutics reaffirms financial guidance after reporting q1 2026 results on may 11 geneonline.com Tue, 26 May 2026 20:56:42 GMT
• acute care revenue growth helps heron (hrtx) reaffirm 2026 guidance despite q1 sales decline MSN Sun, 24 May 2026 23:58:51 GMT
• Why Heron Therapeutics, Inc. (HRTX) Price Target Was Reduced to $4 at H.C. Wainwright? Yahoo Finance Tue, 19 May 2026 07:00:00 GMT
• heron therapeutics (hrtx) price target decreased by 15.38% to 3.74 MSN Mon, 18 May 2026 13:24:18 GMT
• heron therapeutics (hrtx) price target decreased by 15.38% to 3.74 MSN Sun, 17 May 2026 09:48:19 GMT
• heron therapeutics, inc. 2026 q1 - results - earnings call presentation (nasdaq:hrtx) 2026-05-16 Seeking Alpha Sat, 16 May 2026 07:00:00 GMT
• heron therapeutics stock (us4277461020): focus on zynrelef growth and cash runway after latest quart AD HOC NEWS Sat, 16 May 2026 07:00:00 GMT
• heron therapeutics (hrtx) price target decreased by 15.38% to 3.74 MSN Fri, 15 May 2026 15:26:24 GMT
• acute care revenue growth helps heron (hrtx) reaffirm 2026 guidance despite q1 sales decline MSN Fri, 15 May 2026 15:22:24 GMT
• hrtx stock price, quote & chart | heron therapeutics inc (nasdaq:hrtx) ChartMill Fri, 15 May 2026 07:00:00 GMT
• acute care revenue growth helps heron (hrtx) reaffirm 2026 guidance despite q1 sales decline MSN Thu, 14 May 2026 11:41:45 GMT
• heron outlines $173m-$183m 2026 net product sales outlook as it targets return to positive adjusted ebitda MSN Wed, 13 May 2026 21:57:20 GMT
• acute care revenue growth helps heron (hrtx) reaffirm 2026 guidance despite q1 sales decline MSN Wed, 13 May 2026 15:11:45 GMT
• adage capital amendment shows 0% ownership in heron therapeutics (hrtx) Stock Titan Wed, 13 May 2026 07:00:00 GMT
• h.c. wainwright maintains heron therapeutics(hrtx.us) with buy rating, maintains target price $4 Moomoo Tue, 12 May 2026 19:45:42 GMT
• Heron Therapeutics (HRTX) Quarterly Loss Revives Dilution Fears And Tests Profitability Narrative simplywall.st Tue, 12 May 2026 07:00:00 GMT
• heron therapeutics, inc. (nasdaq:hrtx) q1 2026 earnings call transcript Insider Monkey Tue, 12 May 2026 07:00:00 GMT
• h.c. wainwright cuts heron therapeutics stock price target on weak q1 results Investing.com Tue, 12 May 2026 07:00:00 GMT
• heron therapeutics, inc. form 10-q: financial results, forward-looking statements, and key risks for q1 2026 Minichart Tue, 12 May 2026 07:00:00 GMT
• needham maintains heron therapeutics(hrtx.us) with buy rating, maintains target price $3 富途牛牛 Tue, 12 May 2026 07:00:00 GMT
• heron therapeutics inc (hrtx) q1 2026 earnings call highlights: resilient growth amidst challenges by gurufocus Investing.com Canada Tue, 12 May 2026 06:54:19 GMT
• heron therapeutics faces tight covenant constraints that threaten liquidity and strategic flexibility TipRanks Tue, 12 May 2026 06:10:37 GMT
• needham maintains heron therapeutics(hrtx.us) with buy rating, maintains target price $3 Moomoo Mon, 11 May 2026 21:32:00 GMT
• heron therapeutics price target lowered to $4 from $6 at h.c. wainwright TipRanks Mon, 11 May 2026 19:10:06 GMT
• heron outlines $173m-$183m 2026 net product sales outlook as it targets return to positive adjusted ebitda MSN Mon, 11 May 2026 17:59:50 GMT
• heron therapeutics, inc. form 10-q: financial results, forward-looking statements, and key risks for q1 2026 Minichart Mon, 11 May 2026 17:41:00 GMT
• heron therapeutics, inc. reaffirms earnings guidance for the full year 2026 marketscreener.com Mon, 11 May 2026 15:52:21 GMT
• hrtx: q1 sales reached $34.7m, rebounding in march, with strong growth and full-year guidance reaffirmed TradingView Mon, 11 May 2026 14:16:58 GMT
• hrtx: q1 sales hit $34.7m, acute care up 32% yoy, guidance reaffirmed, and commercial expansion planned TradingView Mon, 11 May 2026 13:51:31 GMT
• heron therapeutics inc reports results for the quarter ended march 31 - earnings summary TradingView Mon, 11 May 2026 13:32:17 GMT
• heron therapeutics q1 results miss, but acute care growth and reaffirmed outlook support hrtx ChartMill Mon, 11 May 2026 13:20:27 GMT
• heron therapeutics' q1 revenue falls as oncology sales drop TradingView Mon, 11 May 2026 12:12:20 GMT
• Heron Therapeutics Announces First Quarter 2026 Financial Results and Reaffirms Guidance GlobeNewswire Mon, 11 May 2026 07:00:00 GMT
• Heron Therapeutics, Inc. Q1 2026 Earnings Call Summary Yahoo Finance Mon, 11 May 2026 07:00:00 GMT
• Heron Therapeutics (HRTX) Reports Q1 Loss, Lags Revenue Estimates Yahoo Finance Mon, 11 May 2026 07:00:00 GMT
• Acute Care Revenue Growth Helps Heron (HRTX) Reaffirm 2026 Guidance Despite Q1 Sales Decline Yahoo Finance Mon, 11 May 2026 07:00:00 GMT
• H.C. Wainwright Maintains Heron Therapeutics(HRTX.US) With Buy Rating, Cuts Target Price to $4 富途牛牛 Mon, 11 May 2026 07:00:00 GMT
• Heron Therapeutics Reports Q1 2026 Results: 32% Acute Care Revenue Growth, Reaffirms 2026 Guidance Minichart Mon, 11 May 2026 07:00:00 GMT
• earnings call transcript: heron therapeutics q1 2026 results miss forecasts, stock drops Investing.com Mon, 11 May 2026 07:00:00 GMT
• [8-k] heron therapeutics, inc. /de/ reports material event Stock Titan Mon, 11 May 2026 07:00:00 GMT
• heron therapeutics, inc. reports earnings results for the first quarter ended march 31, 2026 marketscreener.com Mon, 11 May 2026 07:00:00 GMT
• heron therapeutics (hrtx) reports q1 earnings: what key metrics have to say Yahoo Finance Mon, 11 May 2026 07:00:00 GMT
• heron therapeutics (nasdaq:hrtx) releases earnings results, misses expectations by $0.01 eps MarketBeat Mon, 11 May 2026 07:00:00 GMT
• heron therapeutics, inc. /de/ 1q 2026: revenue $34.7m, eps $(0.04) — 10-q summary TradingView Mon, 11 May 2026 07:00:00 GMT
• heron therapeutics (hrtx) swings to q1 2026 loss as oncology sales fall and interest costs rise Stock Titan Mon, 11 May 2026 07:00:00 GMT
• acute-care net revenue up 32% as heron settles cinvanti patent case Stock Titan Mon, 11 May 2026 07:00:00 GMT
• heron therapeutics inc expected to post a loss of 1 cent a share - earnings preview TradingView Fri, 08 May 2026 15:33:08 GMT
• earnings preview: hrtx to report financial results pre-market on may 11 Moomoo Fri, 08 May 2026 06:42:34 GMT
• heron therapeutics (hrtx) coo acquires 125,000 shares via rsu exercise Stock Titan Thu, 07 May 2026 07:00:00 GMT
• earnings preview: hrtx to report financial results pre-market on may 11 富途牛牛 Wed, 06 May 2026 05:23:26 GMT
• analysts estimate heron therapeutics (hrtx) to report a decline in earnings: what to look out for MSN Tue, 05 May 2026 20:00:03 GMT
• needham maintains heron therapeutics(hrtx.us) with buy rating, maintains target price $3 富途牛牛 Mon, 04 May 2026 07:07:24 GMT
• h.c. wainwright maintains heron therapeutics(hrtx.us) with buy rating, maintains target price $6 富途牛牛 Mon, 04 May 2026 07:04:04 GMT
• Analysts Estimate Heron Therapeutics (HRTX) to Report a Decline in Earnings: What to Look Out for Yahoo Finance Mon, 04 May 2026 07:00:00 GMT
Heron Therapeutics, Inc(NASDAQ:HRTX) 
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet medical needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents o...
Website: http://www.herontx.com
Founded: 1983
Full Time Employees: 231
Sector: Healthcare
Industry: Biotechnology